Perceptions of medicines improving
The newly elected chairman of the National Office of Animal Health (NOAH) spoke of the increasingly positive perceptions of animal medicines at the organisation's annual dinner in London.
John Hanley, managing director of Zoetis UK, was announced as the new chairman during the dinner.
Speaking of perceptions of animal medicines among the general public, Mr Hanley said a recent NOAH consumer survey indicates public concerns over animal medicines remain low, far lower than concern over animal living conditions and food production hygiene.
"This is a good time for our industry," he said. "The public are becoming increasingly aware of the value of the work we do both in terms of care for their companion animals and for animals in the food chain."
Commenting on the upcoming European Veterinary Medicines Regulatory review, Mr Hanley voiced his hope that this could offer an opportunity to extend patents and bring about a single market for veterinary medicines. This, he feels would benefit research and development, thereby improving animal welfare.
He concluded: "In the 27 years since the inception of NOAH, the need for the association is as strong today as ever it was, and we have a strong association.
"Our role in giving the industry view to UK and EU regulators is important for access to the market, new product registrations and innovation."
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
